U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07850102) titled 'Brain Imaging of DSP-2342' on Sept. 24.
Brief Summary: The investigators aim to determine the effects of a novel drug on brain function and brain chemistry in patients with schizophrenia.
Study Start Date: Jan. 01, 2027
Study Type: INTERVENTIONAL
Condition:
SCHIZOPHRENIA 1 (Disorder)
Intervention:
DRUG: DSP-2342
a single oral dose of DSP-2342 on brain chemistry and brain activity in adults with schizophrenia.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Johns Hopkins University
Published by HT Digital Content Services with permission from Health Daily Digest....